Applied Molecular Transport Announces Board Appointments
January 27, 2022 16:30 ET
|
Applied Molecular Transport Inc.
John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair Helen S. Kim Named Lead Independent Director SOUTH SAN FRANCISCO, Calif.,...
Day One Appoints Jaa Roberson as Chief People Officer
September 13, 2021 07:00 ET
|
Day One Biopharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing...
Carbapenem-Resistant Enterobacteriaceae Infection Market Research Report 2021: Marketed Products, Emerging Therapies, Major Markets, Epidemiology
August 09, 2021 04:33 ET
|
Research and Markets
Dublin, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The "Carbapenem-Resistant Enterobacteriaceae Infection - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to...
CymaBay Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13, 2021 16:06 ET
|
CymaBay Therapeutics, Inc.
Highly experienced executives, Dr. Dennis Kim as Chief Medical Officer and Lewis Stuart as Chief Commercial Officer, strengthen the management team Biopharma leaders, Thomas Wiggans and Janet...
CymaBay Appoints Thomas Wiggans and Janet Dorling to Board of Directors
April 05, 2021 08:00 ET
|
CymaBay Therapeutics, Inc.
NEWARK, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic...
Global Urinary Tract Infection Treatment Markets, 2020-2027 - Market for Penicillin and Combination Drugs Segment to Grow at Highest Rate
February 09, 2021 04:38 ET
|
Research and Markets
Dublin, Feb. 09, 2021 (GLOBE NEWSWIRE) -- The "Urinary Tract Infection Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class, Indication, Distribution Channel, and...
Global Antibiotic Resistance Markets to 2024: Examine 6 Key Opportunity Areas
October 01, 2020 04:09 ET
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type 2020 To 2024" report has been added to ResearchAndMarkets.com's offering. ...
Global Antibiotic Resistance Markets Report 2020: Analysis and Forecasts 2017-2019 & 2020-2023 with Profiles of 100+ Companies
September 30, 2020 04:29 ET
|
Research and Markets
Dublin, Sept. 30, 2020 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type With Situation Analysis, Executive & Investor Guides & Customization...
Global Biodefense Industry
September 10, 2020 04:50 ET
|
ReportLinker
New York, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Biodefense Industry" - https://www.reportlinker.com/p05961247/?utm_source=GNW 5 Billion by...
Vaxcyte Appoints Halley E. Gilbert to Board of Directors
June 03, 2020 08:30 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...